HHS announced Jan. 10 that payers must cover at-home COVID-19 tests effective Jan. 15. However, insurers raised concerns that the quick turnaround to implement coverage and reimbursement policies would lead to a messy rollout.
The study reviewed publicly available at-home COVID-19 test reimbursement policies from 13 insurers between Jan. 18-20.
Six insurers offered members direct coverage for tests, allowing members to purchase tests without upfront costs without the need to go through a reimbursement process.
Of these six insurers, five have posted steps members can take to get reimbursed if a test was purchased outside of the payer’s preferred network. Five insurers outlined that payers may only be reimbursed up to $12 per test for purchasing at-home COVID-19 tests outside of preferred networks.
The remaining seven insurers implemented reimbursement processes: four opted on mail or fax filing, two opted for online filing and one opted for non-specified methods for members to be reimbursed.
A full list of how the 13 insurers are handling test coverage can be found here.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.